Transcriptional but not translational regulation of HIV-1 by the tat gene product
- PMID: 2833703
- DOI: 10.1038/332551a0
Transcriptional but not translational regulation of HIV-1 by the tat gene product
Abstract
Human immunodeficiency virus-1 (HIV-1), which causes AIDS (acquired immune deficiency syndrome), possesses an essential gene, tat, whose product, acting through the long terminal repeat (LTR) sequences of HIV-1, activates viral genes and replication. The mechanism by which tat trans-activates HIV genes is unclear. Some studies have reported that an increase in messenger RNA accumulation directed by the HIV-1 LTR can explain the action of tat, but others suggest that this increase in mRNA levels can only partially explain trans-activation, and that translational control mechanisms may also be involved. To test those possibilities we have established an efficient adenovirus system for delivering the HIV-1 LTR attached to a reporter gene (chloramphenicol acetyltransferase; CAT) into cells and monitoring its activity. The HIV-1 LTR expressed from this adenovirus responds to trans-activation in a HeLa cell line constitutively expressing the tat protein by increasing the transcription rate of the HIV-1 LTR and the accumulation of mRNA encoding CAT. In this system the translational efficiency of this CAT mRNA in the cell is unaffected by the presence of tat.
Similar articles
-
Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.Nature. 1987 Dec 3-9;330(6147):489-93. doi: 10.1038/330489a0. Nature. 1987. PMID: 2825027
-
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B.Biotechniques. 1991 Mar;10(3):344-53. Biotechniques. 1991. PMID: 1829615
-
Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.Virology. 1997 Jan 20;227(2):431-8. doi: 10.1006/viro.1996.8346. Virology. 1997. PMID: 9018142
-
Tackling Tat.J Mol Biol. 1999 Oct 22;293(2):235-54. doi: 10.1006/jmbi.1999.3060. J Mol Biol. 1999. PMID: 10550206 Review.
-
Activation of HIV transcription by Tat.Curr Opin Genet Dev. 1992 Apr;2(2):293-8. doi: 10.1016/s0959-437x(05)80287-4. Curr Opin Genet Dev. 1992. PMID: 1638124 Review.
Cited by
-
Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region.Proc Natl Acad Sci U S A. 1989 Jul;86(13):4858-62. doi: 10.1073/pnas.86.13.4858. Proc Natl Acad Sci U S A. 1989. PMID: 2544877 Free PMC article.
-
Genetic variation and HIV-associated neurologic disease.Adv Virus Res. 2013;87:183-240. doi: 10.1016/B978-0-12-407698-3.00006-5. Adv Virus Res. 2013. PMID: 23809924 Free PMC article. Review.
-
Cell type-specific anti-human immunodeficiency virus type 1 activity of the transactivation inhibitor Ro5-3335.Antimicrob Agents Chemother. 1992 Dec;36(12):2628-33. doi: 10.1128/AAC.36.12.2628. Antimicrob Agents Chemother. 1992. PMID: 1282790 Free PMC article.
-
Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1.J Virol. 1988 Dec;62(12):4523-32. doi: 10.1128/JVI.62.12.4523-4532.1988. J Virol. 1988. PMID: 2846868 Free PMC article.
-
Arginine-rich regions succeeding the nuclear localization region of the herpes simplex virus type 1 regulatory protein ICP27 are required for efficient nuclear localization and late gene expression.J Virol. 1995 Aug;69(8):4656-67. doi: 10.1128/JVI.69.8.4656-4667.1995. J Virol. 1995. PMID: 7609030 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous